These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 19725590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Michaelis-Menten kinetics determine cyclosporine steady-state concentrations: a population analysis in kidney transplant patients.
    Grevel J, Post BK, Kahan BD.
    Clin Pharmacol Ther; 1993 Jun; 53(6):651-60. PubMed ID: 8513657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Mathematical Treatment of Multiple Intermittent Intravenous Infusions in a One-Compartment Model.
    Savva M.
    Comput Methods Programs Biomed; 2021 Jun; 205():106103. PubMed ID: 33915509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Validity of the Michaelis-Menten equation--steady-state or reactant stationary assumption: that is the question.
    Schnell S.
    FEBS J; 2014 Jan; 281(2):464-72. PubMed ID: 24245583
    [Abstract] [Full Text] [Related]

  • 13. Relationships among duration of infusion, dose, dosing interval, and steady-state plasma concentrations during intermittent intravenous infusions: studies with metronidazole.
    Uccellini DA, Morgan DJ, Raymond K.
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):95-106. PubMed ID: 3746634
    [Abstract] [Full Text] [Related]

  • 14. The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km.
    Bentz J, Tran TT, Polli JW, Ayrton A, Ellens H.
    Pharm Res; 2005 Oct; 22(10):1667-77. PubMed ID: 16180124
    [Abstract] [Full Text] [Related]

  • 15. Confounding issues in estimation of patient-specific pharmacokinetic parameters and dosage individualization of aminoglycosides.
    Mehvar R.
    Curr Clin Pharmacol; 2012 Feb 01; 7(1):28-35. PubMed ID: 22299767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.
    Jodrell DI, Reyno LM, Sridhara R, Eisenberger MA, Tkaczuk KH, Zuhowski EG, Sinibaldi VJ, Novak MJ, Egorin MJ.
    J Clin Oncol; 1994 Jan 01; 12(1):166-75. PubMed ID: 8270974
    [Abstract] [Full Text] [Related]

  • 18. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG, Szpunar GJ, Ferry JJ.
    J Pharmacokinet Biopharm; 1985 Feb 01; 13(1):73-92. PubMed ID: 4020623
    [Abstract] [Full Text] [Related]

  • 19. Constant infusion case of one compartment pharmacokinetic model with simultaneous first-order and Michaelis-Menten elimination: analytical solution and drug exposure formula.
    Wu X, Chen M, Li J.
    J Pharmacokinet Pharmacodyn; 2021 Aug 01; 48(4):495-508. PubMed ID: 33629256
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.